Biohit Oyj - Managers' Transactions


 Biohit Oyj - Managers' Transactions, February 24, 2017 at 2:40 pm local time (EET)

Person subject to the notification requirement
Name: Patrakka, Ilari  
Position: Other senior manager
     
Initial Notification  
Reference number: 74370089ATTSNBXJVT29_20170224110020_10
     
Issuer
Name: Biohit Oyj
LEI: 74370089ATTSNBXJVT29
     
Transaction details
Transaction date: 2017-02-23
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Disposal
Further details:  
  Linked to stock option programme
 
Instrument: Financial Instrument Linked to a Share or a Debt Instrument
ISIN: FI4000219324
 
Volume: 706
Unit price: 0,00000 Euro
 
Aggregated transactions
Volume: 706
Volume weighted average price: 0.00000 Euro

 

Additional information: 

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com


Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com